헬스케어 애널리틱스 시장 규모, 점유율, 동향 분석 보고서 : 종류별, 구성요소별, 제공 방식별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Healthcare Analytics Market Summary

The global healthcare analytics market size was estimated at USD 52.98 billion in 2024 and is projected to reach USD 198.79 billion by 2033, growing at a CAGR of 14.85% from 2025 to 2033. This growth is attributed to the increasing challenges, such as inadequate patient care, rising treatment costs, and low levels of patient retention and engagement.

In addition, the complexity of interpreting marketing analytics is driven by the sheer speed, volume, variety, and questionable authenticity of available data, which further complicates decision-making, significantly drives the role of healthcare analytics in the market. According to an article published by Infosys Limited in December 2022, the healthcare sector currently contributes nearly 30% of the world's total data volume, and this figure is projected to grow at a strong CAGR of 36% through 2025.

A rapid rate of technological advancements and massive investments by the healthcare industry into IT development and digitization have been key factors for the monumental growth of the healthcare analytics industry. In January 2021, Optum, Inc. collaborated with Change Healthcare to advance the technology-enabled healthcare platform. Both companies provide their consumers with data analytics solutions, software, and a technology-advanced healthcare platform. Analytical platforms that are currently being deployed by healthcare institutions across the globe help in patient management and retention, due to which better care can be delivered. Deployment of healthcare analytical platforms not only increases the productivity of staff, but overall patient management has been improved and the burden on caregivers has been minimized.

Government initiatives and a massive flux of money in the healthcare industry also drive innovation. They are responsible for the increasing adoption of such analytical platforms by healthcare establishments. Analytical platforms are used by hospitals and other establishments for managing and interpreting clinical data from various studies conducted, studying historical data and analyzing it to establish trends, and developing methods, tools, and technologies to get optimal results.

Policymakers are also deploying these analytics platforms to study statistics and models for making better decisions and policies regarding healthcare establishments and delivering care to patients. The U.S. government has been taking initiatives in this direction; the HealthData.gov portal has information from several federal databases on topics such as community health performance, clinical data, and medical and scientific knowledge for developers, which is accessible via an application programming interface.

The healthcare marketing analytics is witnessing strong growth driven by the rising adoption of digital health platforms, increasing demand for personalized patient engagement, and the shift toward data-driven decision-making in marketing strategies. Factors such as the integration of AI and predictive analytics, growing use of social media and omnichannel campaigns, and regulatory emphasis on transparent communication are further accelerating adoption. Key healthcare marketing analytics companies include IQVIA, Oracle, SAS Institute, Adobe, and Veeva Systems, focusing on advanced analytics platforms, real-world evidence integration, and cloud-based solutions to help healthcare providers, payers, and life sciences companies optimize outreach, measure ROI, and improve patient-centric marketing outcomes.

Global Healthcare Analytics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global healthcare analyticsmarket report based on type, component, delivery mode, application, end use, and region.

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Descriptive Analysis
• Diagnostic Analytics
• Predictive Analysis
• Prescriptive Analysis
• Component Outlook (Revenue, USD Million, 2021 - 2033)
• Software
• Hardware
• Services
• Delivery Mode Outlook (Revenue, USD Million, 2021 - 2033)
• On-premises
• Web-hosted
• Cloud-based
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Clinical
• Financial
• Operational and Administrative
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Healthcare Payers
• Healthcare Providers
• Life Science Companies
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Component
  • 1.2.3. Delivery mode
  • 1.2.4. Application
  • 1.2.5. End use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Adoption of Big Data and AI in Healthcare
    • 3.2.1.2. Escalating Healthcare Costs Driving Efficiency Needs
    • 3.2.1.3. Growing Volume of Patient Data from EHRs & Wearables
    • 3.2.1.4. Expansion of Personalized & Precision Medicine
    • 3.2.1.5. Integration of Predictive & Prescriptive Analytics
    • 3.2.1.6. Expansion of Omnichannel Marketing Strategies
    • 3.2.1.7. Heightened Competition Among Healthcare Providers and Payers
    • 3.2.1.8. Rising Impact of Internet and Social Media On Healthcare
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Data Privacy and Theft Issues
    • 3.2.2.2. Lack of Skilled Professionals
  • 3.2.3. Industry Opportunity Analysis
  • 3.2.4. Industry Challenge Analysis
  • 3.2.5. Case Studies
• 3.3. Business Environment Analysis
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal Landscape

Chapter 4. Healthcare Analytics Market: Type Estimates & Trend Analysis

• 4.1. Type Segment Dashboard
• 4.2. Type Market Share Movement Analysis, 2024 & 2033
• 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 4.4. Descriptive Analysis
  • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Diagnostic Analytics
  • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Predictive Analysis
  • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Prescriptive Analysis
  • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Healthcare Analytics Market: Component Estimates & Trend Analysis

• 5.1. Component Segment Dashboard
• 5.2. Component Market Share Movement Analysis, 2024 & 2033
• 5.3. Market Size & Forecasts and Trend Analysis, by Component, 2021 to 2033 (USD Million)
• 5.4. Software
  • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Hardware
  • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Services
  • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Healthcare Analytics Market: Delivery Mode Estimates & Trend Analysis

• 6.1. Delivery Mode Dashboard
• 6.2. Delivery Mode Market Share Movement Analysis, 2024 & 2033
• 6.3. Market Size & Forecasts and Trend Analysis, by Delivery Mode, 2021 to 2033 (USD Million)
• 6.4. On-premise
  • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Web-hosted
  • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Cloud-based
  • 6.6.1.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Healthcare Analytics Market: Application Estimates & Trend Analysis

• 7.1. Application Mode Dashboard
• 7.2. Application Market Share Movement Analysis, 2024 & 2033
• 7.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 7.4. Clinical
  • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Financial
  • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Operational and Administrative
  • 7.6.1.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Healthcare Analytics Market: End Use Estimates & Trend Analysis

• 8.1. End use Segment Dashboard
• 8.2. End use Market Share Movement Analysis, 2024 & 2033
• 8.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 8.4. Healthcare Providers
  • 8.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Healthcare Payers
  • 8.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Life Sciences Companies
  • 8.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Healthcare Analytics Market: Regional Estimates & Trend Analysis

• 9.1. Regional Market Dashboard
• 9.2. Regional Market: Key Takeaways
• 9.3. North America
  • 9.3.1. North America Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Key country dynamic
    • 9.3.2.2. Regulatory framework
    • 9.3.2.3. Competitive insights
    • 9.3.2.4. U.S. Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Key country dynamic
    • 9.3.3.2. Regulatory framework
    • 9.3.3.3. Competitive insights
    • 9.3.3.4. Canada Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.3.4. Mexico
    • 9.3.4.1. Key country dynamic
    • 9.3.4.2. Regulatory framework
    • 9.3.4.3. Competitive insights
    • 9.3.4.4. Mexico Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.4. Europe
  • 9.4.1. Europe Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.2. Germany
    • 9.4.2.1. Key country dynamic
    • 9.4.2.2. Regulatory framework
    • 9.4.2.3. Competitive insights
    • 9.4.2.4. Germany Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.3. UK
    • 9.4.3.1. Key country dynamic
    • 9.4.3.2. Regulatory framework
    • 9.4.3.3. Competitive insights
    • 9.4.3.4. UK Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.4. France
    • 9.4.4.1. Key country dynamic
    • 9.4.4.2. Regulatory framework
    • 9.4.4.3. Competitive insights
    • 9.4.4.4. France Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.5. Italy
    • 9.4.5.1. Key country dynamic
    • 9.4.5.2. Regulatory framework
    • 9.4.5.3. Competitive insights
    • 9.4.5.4. Italy Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.6. Spain
    • 9.4.6.1. Key country dynamic
    • 9.4.6.2. Regulatory framework
    • 9.4.6.3. Competitive insights
    • 9.4.6.4. Spain Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.7. Denmark
    • 9.4.7.1. Key country dynamic
    • 9.4.7.2. Regulatory framework
    • 9.4.7.3. Competitive insights
    • 9.4.7.4. Denmark Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.8. Sweden
    • 9.4.8.1. Key country dynamic
    • 9.4.8.2. Regulatory framework
    • 9.4.8.3. Competitive insights
    • 9.4.8.4. Sweden Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.9. Norway
    • 9.4.9.1. Key country dynamic
    • 9.4.9.2. Regulatory framework
    • 9.4.9.3. Competitive insights
    • 9.4.9.4. Norway Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.2. Japan
    • 9.5.2.1. Key country dynamic
    • 9.5.2.2. Regulatory framework
    • 9.5.2.3. Competitive insights
    • 9.5.2.4. Japan Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.3. China
    • 9.5.3.1. Key country dynamic
    • 9.5.3.2. Regulatory framework
    • 9.5.3.3. Competitive insights
    • 9.5.3.4. China Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.4. India
    • 9.5.4.1. Key country dynamic
    • 9.5.4.2. Regulatory framework
    • 9.5.4.3. Competitive insights
    • 9.5.4.4. India Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.5. South Korea
    • 9.5.5.1. Key country dynamic
    • 9.5.5.2. Regulatory framework
    • 9.5.5.3. Competitive insights
    • 9.5.5.4. South Korea Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.6. Australia
    • 9.5.6.1. Key country dynamic
    • 9.5.6.2. Regulatory framework
    • 9.5.6.3. Competitive insights
    • 9.5.6.4. Australia Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.7. Thailand
    • 9.5.7.1. Key country dynamic
    • 9.5.7.2. Regulatory framework
    • 9.5.7.3. Competitive insights
    • 9.5.7.4. Thailand Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.6. Latin America
  • 9.6.1. Latin America Healthcare Analytics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.2. Brazil
    • 9.6.2.1. Key country dynamic
    • 9.6.2.2. Regulatory framework
    • 9.6.2.3. Competitive insights
    • 9.6.2.4. Brazil Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.6.3. Argentina
    • 9.6.3.1. Key country dynamic
    • 9.6.3.2. Regulatory framework
    • 9.6.3.3. Competitive insights
    • 9.6.3.4. Argentina Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.7. MEA
  • 9.7.1. MEA Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.2. South Africa
    • 9.7.2.1. Key country dynamic
    • 9.7.2.2. Regulatory framework
    • 9.7.2.3. Competitive insights
    • 9.7.2.4. South Africa Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.3. Saudi Arabia
    • 9.7.3.1. Key country dynamic
    • 9.7.3.2. Regulatory framework
    • 9.7.3.3. Competitive insights
    • 9.7.3.4. Saudi Arabia Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.4. UAE
    • 9.7.4.1. Key country dynamic
    • 9.7.4.2. Regulatory framework
    • 9.7.4.3. Competitive insights
    • 9.7.4.4. UAE Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key country dynamic
    • 9.7.5.2. Regulatory framework
    • 9.7.5.3. Competitive insights
    • 9.7.5.4. Kuwait Healthcare analytics market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Participant Overview
• 10.2. Company Market Position Analysis
• 10.3. Company Categorization
• 10.4. Strategy Mapping
• 10.5. Company Profiles/Listing
  • 10.5.1. Oracle
    • 10.5.1.1. Overview
    • 10.5.1.2. Financial performance
    • 10.5.1.3. Product benchmarking
    • 10.5.1.4. Strategic initiatives
  • 10.5.2. McKesson Corporation
    • 10.5.2.1. Overview
    • 10.5.2.2. Financial performance
    • 10.5.2.3. Product benchmarking
    • 10.5.2.4. Strategic initiatives
  • 10.5.3. Optum, Inc.
    • 10.5.3.1. Overview
    • 10.5.3.2. Financial performance
    • 10.5.3.3. Product benchmarking
    • 10.5.3.4. Strategic initiatives
  • 10.5.4. Merative (formerly IBM Watson Health)
    • 10.5.4.1. Overview
    • 10.5.4.2. Financial performance
    • 10.5.4.3. Product benchmarking
    • 10.5.4.4. Strategic initiatives
  • 10.5.5. SAS Institute, Inc.
    • 10.5.5.1. Overview
    • 10.5.5.2. Financial performance
    • 10.5.5.3. Product benchmarking
    • 10.5.5.4. Strategic initiatives
  • 10.5.6. IQVIA
    • 10.5.6.1. Overview
    • 10.5.6.2. Financial performance
    • 10.5.6.3. Product benchmarking
    • 10.5.6.4. Strategic initiatives
  • 10.5.7. Verisk Analytics, Inc.
    • 10.5.7.1. Overview
    • 10.5.7.2. Financial performance
    • 10.5.7.3. Product benchmarking
    • 10.5.7.4. Strategic initiatives
  • 10.5.8. Elsevier
    • 10.5.8.1. Overview
    • 10.5.8.2. Financial performance
    • 10.5.8.3. Product benchmarking
    • 10.5.8.4. Strategic initiatives
  • 10.5.9. Medeanalytics, Inc.
    • 10.5.9.1. Overview
    • 10.5.9.2. Financial performance
    • 10.5.9.3. Product benchmarking
    • 10.5.9.4. Strategic initiatives
  • 10.5.10. Veradigm
    • 10.5.10.1. Overview
    • 10.5.10.2. Financial performance
    • 10.5.10.3. Product benchmarking
    • 10.5.10.4. Strategic initiatives
  • 10.5.11. Cognizant Technology Solutions
    • 10.5.11.1. Overview
    • 10.5.11.2. Financial performance
    • 10.5.11.3. Product benchmarking
    • 10.5.11.4. Strategic initiatives
  • 10.5.12. Infor, Inc.
    • 10.5.12.1. Overview
    • 10.5.12.2. Financial performance
    • 10.5.12.3. Product benchmarking
    • 10.5.12.4. Strategic initiatives
  • 10.5.13. Wipro Limited
    • 10.5.13.1. Overview
    • 10.5.13.2. Financial performance
    • 10.5.13.3. Product benchmarking
    • 10.5.13.4. Strategic initiatives
  • 10.5.14. Infosys Limited
    • 10.5.14.1. Overview
    • 10.5.14.2. Financial performance
    • 10.5.14.3. Product benchmarking
    • 10.5.14.4. Strategic initiatives
  • 10.5.15. Health Catalyst, Inc.
    • 10.5.15.1. Overview
    • 10.5.15.2. Financial performance
    • 10.5.15.3. Product benchmarking
    • 10.5.15.4. Strategic initiatives
  • 10.5.16. Athenahealth, Inc.
    • 10.5.16.1. Overview
    • 10.5.16.2. Financial performance
    • 10.5.16.3. Product benchmarking
    • 10.5.16.4. Strategic initiatives
  • 10.5.17. Cloudera, Inc.
    • 10.5.17.1. Overview
    • 10.5.17.2. Financial performance
    • 10.5.17.3. Product benchmarking
    • 10.5.17.4. Strategic initiatives
  • 10.5.18. Komodo Health
    • 10.5.18.1. Overview
    • 10.5.18.2. Financial performance
    • 10.5.18.3. Product benchmarking
    • 10.5.18.4. Strategic initiatives
  • 10.5.19. Definitive Healthcare, LLC
    • 10.5.19.1. Overview
    • 10.5.19.2. Financial performance
    • 10.5.19.3. Product benchmarking
    • 10.5.19.4. Strategic initiatives